Search Results for 'Tenofovir'

Tenofovir published presentations and documents on DocSlides.

The Bangkok Tenofovir Study
The Bangkok Tenofovir Study
by marina-yarberry
An HIV pre-exposure prophylaxis trial in Thailand...
Tenofovir nephrotoxicity in resource limited setting of Western India : Higher rate of renal functi
Tenofovir nephrotoxicity in resource limited setting of Western India : Higher rate of renal functi
by conchita-marotz
A.Dravid. 1. ,A.Sadre. 2. ,S.Dhande. 1. , A.Borka...
Switching the NRTI Backbone to Tenofovir DF-Emtricitabine
Switching the NRTI Backbone to Tenofovir DF-Emtricitabine
by reese
TOTEM. Switching the NRTI Backbone to Tenofovir DF...
Switch NRTIs to Tenofovir DF-Emtricitabine or Abacavir-Lamivudine
Switch NRTIs to Tenofovir DF-Emtricitabine or Abacavir-Lamivudine
by kylie
STEAL. Switch NRTIs to Tenofovir DF-Emtricitabine ...
Simplification to Efavirenz-Tenofovir DF-Emtricitabine
Simplification to Efavirenz-Tenofovir DF-Emtricitabine
by valerie
ADONE Trial. Simplification to Efavirenz-Tenofovir...
HIV Medication Overview
HIV Medication Overview
by kittie-lecroy
John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. A...
State
State
by pasty-toler
of the evidence from oral and topical . PrEP. ef...
Tenofovir
Tenofovir
by alida-meadow
based . PrEP. technologies in women : . what do...
Major Changes to the HHS Adult and Adolescent HIV Treatment
Major Changes to the HHS Adult and Adolescent HIV Treatment
by tawny-fly
Brian R. Wood, MD. Assistant Professor of Medicin...
Antiretroviral Updates:
Antiretroviral Updates:
by tatyana-admore
New Treatments for HIV. C. Ryan Tomlin, . Pharm.D...
Conflict of Interest “No conflicts of interest to declare”
Conflict of Interest “No conflicts of interest to declare”
by karlyn-bohler
Lessons Learned from Tenofovir Vaginal Gel Studie...
Florida  AIDS Drug Assistance
Florida AIDS Drug Assistance
by liane-varnes
Program. Improving Health. . . Promoting Wellness...
ART Initiation:  PrEP  and
ART Initiation: PrEP and
by alida-meadow
Treatment-naïve Patients . Clinical Instructor, ...
HIV Pharmacotherapy Focused Update
HIV Pharmacotherapy Focused Update
by yoshiko-marsland
Drew Lambert, . PharmD. lambertd@husson.edu. Huss...
New  Antiretrovirals  for the Treatment
New Antiretrovirals for the Treatment
by alida-meadow
of HIV. . Convenience, tolerability, simplicity....
Florida  AIDS Drug Assistance
Florida AIDS Drug Assistance
by natalia-silvester
Program. Improving Health. . . Promoting Wellness...
Florida  AIDS Drug Assistance
Florida AIDS Drug Assistance
by yoshiko-marsland
Program. Improving Health. . . Promoting Wellness...
Generic  tenofovir   disoproxil
Generic tenofovir disoproxil
by SunkissedBabe
fumarate and . emtricitabine. tablets obtained fr...
Switching from TDF/FTC to TAF/
Switching from TDF/FTC to TAF/
by fanny
FTC. Study 311-1089. Switching from TDF/FTC to TAF...
F.G.M.RusselTable2.1
F.G.M.RusselTable2.1
by liane-varnes
GeneProteinMechanismTissuedistributionlocalization...
Managing Antiretroviral Failure in 2012
Managing Antiretroviral Failure in 2012
by sherrill-nordquist
Jennifer Hoy. , MBBS. Professor of Medicine. Dire...
EFFECTS ON RENAL FUNCTION OF A SWITCH FROM TENOFOVIR (TDF)
EFFECTS ON RENAL FUNCTION OF A SWITCH FROM TENOFOVIR (TDF)
by tawny-fly
M Harris, . S Guillemi. , K Chan, B Yip. ,. . M ...
W orking
W orking
by min-jolicoeur
with . Different Groups. Module 3 (f). People who...
New Prevention Technologies Workshop
New Prevention Technologies Workshop
by olivia-moreira
Module 5: . State of NPT Research. www.icad-cisd....
ID Week Review 2015
ID Week Review 2015
by briana-ranney
Brian R. Wood, MD. Assistant Professor of Medicin...
Comparison of Adherence among Partners’ PrEP Participants on Placebo before and after Release of
Comparison of Adherence among Partners’ PrEP Participants on Placebo before and after Release of
by briana-ranney
B. Wamuti. , J. Odoyo, B. Rono, C. Cohen, E. Buku...
AHCCCS Pharmacy and Therapeutics Committee
AHCCCS Pharmacy and Therapeutics Committee
by debby-jeon
August 16, 2016. 5-17-16 Minutes. Review and vote...
Pre- and Post-Exposure Prophylaxis for HIV
Pre- and Post-Exposure Prophylaxis for HIV
by stefany-barnette
Kevin L. Ard, MD, MPH. October 20, 2016. Learning...
Pre-exposure Prophylaxis for HIV Prevention
Pre-exposure Prophylaxis for HIV Prevention
by pamella-moone
Efficacy and the importance of adherence. Joanne ...
Projecting  the Impact of
Projecting the Impact of
by marina-yarberry
Generic. HIV . Drugs. on 90-90-90. Esteban Burr...
Areas of Work Regulatory System Strengthening
Areas of Work Regulatory System Strengthening
by marina-yarberry
Access and Rational Use. Blood, Radiological and ...
2014: HIV, HCV, and  HBV
2014: HIV, HCV, and HBV
by kittie-lecroy
Update. David Spach, MD. Professor of Medicine,...
HIV Pharmacotherapy Focused Update
HIV Pharmacotherapy Focused Update
by sherrill-nordquist
Drew Lambert, . PharmD. lambertd@husson.edu. Huss...
SHIV Infection and Drug Transporters Influence Brain Tissue Concentrations of Efavirenz
SHIV Infection and Drug Transporters Influence Brain Tissue Concentrations of Efavirenz
by tatiana-dople
Nithya Srinivas. 1. , John Fallon. 1. , Craig Syk...
Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, N
Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, N
by briana-ranney
Guidelines for Prevention and Treatment of Opport...
ACTHIV 2018:  A State-of-the-Science Conference for Frontline Health Professionals
ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals
by phoebe-click
ACTIVITY CODE . TD342. Antiretroviral Medications...
HBV Clinical Management [TRAINER(S) NAME(S)] IAPAC African Regional
HBV Clinical Management [TRAINER(S) NAME(S)] IAPAC African Regional
by mitsue-stanley
HBV Clinical Management [TRAINER(S) NAME(S)] IAPA...
TENOFOVIR ALAFENAMIDE PHARMACOKINETICS
TENOFOVIR ALAFENAMIDE PHARMACOKINETICS
by studyne
WITH AND WITHOUT COBICISTAT IN PREGNANCY . Jeremia...
Evolving Options for HBV Therapy:
Evolving Options for HBV Therapy:
by desiron
Navigating the New Treatment Landscape. Outline. I...